/Companies

Abalos Therapeutics

4 known investors

Find your way into Abalos Therapeutics

Sign up to find every way you can get introduced to Abalos Therapeutics

  • Your email: who you already know at Abalos Therapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Abalos Therapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Abalos Therapeutics develops immunotherapy treatments using arenavirus-based approaches for cancer. The company serves cancer patients and is located in Germany, operating in the biotech sector.

Investors · 4

Funding

SEC filings, press & company announcements

$12M disclosed across 1 of 2 rounds · 2019–2021

  • Undisclosed amountSeries A ExtensionOct 2021 · 2 sources
    Source ↗
  • $12MSeries AOct 2019 · 2 sources
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Abalos Therapeutics do?
Abalos Therapeutics develops immunotherapy treatments using arenavirus-based approaches for cancer. The company serves cancer patients and is located in Germany, operating in the biotech sector.
Who are Abalos Therapeutics's investors?
Abalos Therapeutics's investors include coparion, Ventura BioMed Investors, Apollo Health Ventures, Boehringer Ingelheim Venture Fund.
How much funding has Abalos Therapeutics raised?
Abalos Therapeutics has disclosed $12M raised across 1 of its 2 known rounds.